The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
PX-171-003-A1, an open-label, single-arm, phase (Ph) II study of carfilzomib (CFZ) in patients (pts) with relapsed and refractory multiple myeloma (R/R MM): Long-term follow-up and subgroup analysis.
D. S. D. Siegel
Consultant or Advisory Role - Celgene; Millennium
Honoraria - Celgene; Millennium
T. Martin
Consultant or Advisory Role - Onyx
Honoraria - Celgene
M. Wang
Research Funding - Celgene; Millennium; Novartis; Onyx
R. Vij
Consultant or Advisory Role - Celgene; Millennium; Onyx
Honoraria - Celgene; Millennium; Onyx
Research Funding - Celgene; Onyx
S. Lonial
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Millennium; Novartis; Onyx
Research Funding - Bristol-Myers Squibb; Celgene; Millennium; Novartis; Onyx
V. Kukreti
Honoraria - Celgene; Ortho Biotech; Roche
N. J. Bahlis
No relevant relationships to disclose
M. Alsina
Consultant or Advisory Role - Millennium; Novartis
Research Funding - Celgene; Millennium
G. Somlo
No relevant relationships to disclose
F. Buadi
No relevant relationships to disclose
F. J. Reu
No relevant relationships to disclose
K. W. Song
No relevant relationships to disclose
L. A. Kunkel
Stock Ownership - Onyx; Onyx
A. Wong
Employment or Leadership Position - Onyx
Stock Ownership - Onyx
M. Vallone
Employment or Leadership Position - Onyx
Stock Ownership - Onyx
R. Z. Orlowski
No relevant relationships to disclose
A. K. Stewart
Consultant or Advisory Role - Millennium
Honoraria - Celgene
S. Singhal
Employment or Leadership Position - Celgene; Millennium; Takeda
Consultant or Advisory Role - Celgene; Millennium; Takeda
Research Funding - Onyx
S. Jagannath
Employment or Leadership Position - Imedex; Medicom Worldwide; OptumHealth; PER Group
Honoraria - Celgene; Merck; Millennium; Onyx; Ortho Biotech
A. J. Jakubowiak
Employment or Leadership Position - Bristol-Myers Squibb (U); Centocor Ortho Biotech (U); Exelixis (U); Millennium (U)
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Centocor Ortho Biotech; Exelixis; Millennium
Honoraria - Bristol-Myers Squibb; Celgene; Centocor Ortho Biotech; Exelixis; Millennium